The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Autoimmune Disease Treatment-Global Market Insights and Sales Trends 2024
Synopsis
Autoimmune diseases is a body’s hyperactive immune response against the substances and tissues normally present in the body. Autoimmune diseases are more commonly caused by genetic, infectious or environmental factors.
The global Autoimmune Disease Treatment market size is expected to reach US$ 119350 million by 2029, growing at a CAGR of 2.4% from 2023 to 2029. The market is mainly driven by the significant applications of Autoimmune Disease Treatment in various end use industries. The expanding demands from the Hospitals, Clinics, Drug Stores and Other, are propelling Autoimmune Disease Treatment market. Immunosuppressant’s, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Anti-Inflammatory Drugs segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Sale Channel. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Autoimmune Disease Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Autoimmune Disease Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Autoimmune Disease Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Autoimmune Disease Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Autoimmune Disease Treatment covered in this report include Abbott Laboratories, Active Biotech, Eli Lilly, Bristol-Myers Squibb, AstraZeneca plc, Pfizer, Biogen Idec, Lupin Limited and GlaxoSmithKline, etc.
The global Autoimmune Disease Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Active Biotech
Eli Lilly
Bristol-Myers Squibb
AstraZeneca plc
Pfizer
Biogen Idec
Lupin Limited
GlaxoSmithKline
Amgen
4SC AG
F. Hoffmann-La Roche Ltd.
AutoImmune Inc
Johnson & Johnson
Bayer
Global Autoimmune Disease Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Autoimmune Disease Treatment market, Segment by Type:
Immunosuppressant’s
Anti-Inflammatory Drugs
Corticosteroids
Nonsteroidal Anti-inflammatory Drugs
Biologics
Global Autoimmune Disease Treatment market, by Sale Channel
Hospitals
Clinics
Drug Stores
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Sale Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Autoimmune Disease Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Autoimmune diseases is a body’s hyperactive immune response against the substances and tissues normally present in the body. Autoimmune diseases are more commonly caused by genetic, infectious or environmental factors.
The global Autoimmune Disease Treatment market size is expected to reach US$ 119350 million by 2029, growing at a CAGR of 2.4% from 2023 to 2029. The market is mainly driven by the significant applications of Autoimmune Disease Treatment in various end use industries. The expanding demands from the Hospitals, Clinics, Drug Stores and Other, are propelling Autoimmune Disease Treatment market. Immunosuppressant’s, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Anti-Inflammatory Drugs segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Sale Channel. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Autoimmune Disease Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Autoimmune Disease Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Autoimmune Disease Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Autoimmune Disease Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Autoimmune Disease Treatment covered in this report include Abbott Laboratories, Active Biotech, Eli Lilly, Bristol-Myers Squibb, AstraZeneca plc, Pfizer, Biogen Idec, Lupin Limited and GlaxoSmithKline, etc.
The global Autoimmune Disease Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Active Biotech
Eli Lilly
Bristol-Myers Squibb
AstraZeneca plc
Pfizer
Biogen Idec
Lupin Limited
GlaxoSmithKline
Amgen
4SC AG
F. Hoffmann-La Roche Ltd.
AutoImmune Inc
Johnson & Johnson
Bayer
Global Autoimmune Disease Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Autoimmune Disease Treatment market, Segment by Type:
Immunosuppressant’s
Anti-Inflammatory Drugs
Corticosteroids
Nonsteroidal Anti-inflammatory Drugs
Biologics
Global Autoimmune Disease Treatment market, by Sale Channel
Hospitals
Clinics
Drug Stores
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Sale Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Autoimmune Disease Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Autoimmune Disease Treatment
1.1 Autoimmune Disease Treatment Market Overview
1.1.1 Autoimmune Disease Treatment Product Scope
1.1.2 Autoimmune Disease Treatment Market Status and Outlook
1.2 Global Autoimmune Disease Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Autoimmune Disease Treatment Market Size by Region (2018-2029)
1.4 Global Autoimmune Disease Treatment Historic Market Size by Region (2018-2023)
1.5 Global Autoimmune Disease Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Autoimmune Disease Treatment Market Size (2018-2029)
1.6.1 North America Autoimmune Disease Treatment Market Size (2018-2029)
1.6.2 Europe Autoimmune Disease Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Autoimmune Disease Treatment Market Size (2018-2029)
1.6.4 Latin America Autoimmune Disease Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Autoimmune Disease Treatment Market Size (2018-2029)
2 Autoimmune Disease Treatment Market by Type
2.1 Introduction
2.1.1 Immunosuppressant’s
2.1.2 Anti-Inflammatory Drugs
2.1.3 Corticosteroids
2.1.4 Nonsteroidal Anti-inflammatory Drugs
2.1.5 Biologics
2.2 Global Autoimmune Disease Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Autoimmune Disease Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Autoimmune Disease Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Autoimmune Disease Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Autoimmune Disease Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Autoimmune Disease Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Autoimmune Disease Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Autoimmune Disease Treatment Revenue Breakdown by Type (2018-2029)
3 Autoimmune Disease Treatment Market Overview by Sale Channel
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Drug Stores
3.1.4 Other
3.2 Global Autoimmune Disease Treatment Market Size by Sale Channel: 2018 VS 2022 VS 2029
3.2.1 Global Autoimmune Disease Treatment Historic Market Size by Sale Channel (2018-2023)
3.2.2 Global Autoimmune Disease Treatment Forecasted Market Size by Sale Channel (2024-2029)
3.3 Key Regions Market Size by Sale Channel
3.3.1 North America Autoimmune Disease Treatment Revenue Breakdown by Sale Channel (2018-2029)
3.3.2 Europe Autoimmune Disease Treatment Revenue Breakdown by Sale Channel (2018-2029)
3.3.3 Asia-Pacific Autoimmune Disease Treatment Revenue Breakdown by Sale Channel (2018-2029)
3.3.4 Latin America Autoimmune Disease Treatment Revenue Breakdown by Sale Channel (2018-2029)
3.3.5 Middle East and Africa Autoimmune Disease Treatment Revenue Breakdown by Sale Channel (2018-2029)
4 Autoimmune Disease Treatment Competition Analysis by Players
4.1 Global Autoimmune Disease Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Autoimmune Disease Treatment as of 2022)
4.3 Date of Key Players Enter into Autoimmune Disease Treatment Market
4.4 Global Top Players Autoimmune Disease Treatment Headquarters and Area Served
4.5 Key Players Autoimmune Disease Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Autoimmune Disease Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Profile
5.1.2 Abbott Laboratories Main Business
5.1.3 Abbott Laboratories Autoimmune Disease Treatment Products, Services and Solutions
5.1.4 Abbott Laboratories Autoimmune Disease Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Laboratories Recent Developments
5.2 Active Biotech
5.2.1 Active Biotech Profile
5.2.2 Active Biotech Main Business
5.2.3 Active Biotech Autoimmune Disease Treatment Products, Services and Solutions
5.2.4 Active Biotech Autoimmune Disease Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 Active Biotech Recent Developments
5.3 Eli Lilly
5.3.1 Eli Lilly Profile
5.3.2 Eli Lilly Main Business
5.3.3 Eli Lilly Autoimmune Disease Treatment Products, Services and Solutions
5.3.4 Eli Lilly Autoimmune Disease Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 Bristol-Myers Squibb Recent Developments
5.4 Bristol-Myers Squibb
5.4.1 Bristol-Myers Squibb Profile
5.4.2 Bristol-Myers Squibb Main Business
5.4.3 Bristol-Myers Squibb Autoimmune Disease Treatment Products, Services and Solutions
5.4.4 Bristol-Myers Squibb Autoimmune Disease Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 Bristol-Myers Squibb Recent Developments
5.5 AstraZeneca plc
5.5.1 AstraZeneca plc Profile
5.5.2 AstraZeneca plc Main Business
5.5.3 AstraZeneca plc Autoimmune Disease Treatment Products, Services and Solutions
5.5.4 AstraZeneca plc Autoimmune Disease Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 AstraZeneca plc Recent Developments
5.6 Pfizer
5.6.1 Pfizer Profile
5.6.2 Pfizer Main Business
5.6.3 Pfizer Autoimmune Disease Treatment Products, Services and Solutions
5.6.4 Pfizer Autoimmune Disease Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 Pfizer Recent Developments
5.7 Biogen Idec
5.7.1 Biogen Idec Profile
5.7.2 Biogen Idec Main Business
5.7.3 Biogen Idec Autoimmune Disease Treatment Products, Services and Solutions
5.7.4 Biogen Idec Autoimmune Disease Treatment Revenue (US$ Million) & (2018-2023)
5.7.5 Biogen Idec Recent Developments
5.8 Lupin Limited
5.8.1 Lupin Limited Profile
5.8.2 Lupin Limited Main Business
5.8.3 Lupin Limited Autoimmune Disease Treatment Products, Services and Solutions
5.8.4 Lupin Limited Autoimmune Disease Treatment Revenue (US$ Million) & (2018-2023)
5.8.5 Lupin Limited Recent Developments
5.9 GlaxoSmithKline
5.9.1 GlaxoSmithKline Profile
5.9.2 GlaxoSmithKline Main Business
5.9.3 GlaxoSmithKline Autoimmune Disease Treatment Products, Services and Solutions
5.9.4 GlaxoSmithKline Autoimmune Disease Treatment Revenue (US$ Million) & (2018-2023)
5.9.5 GlaxoSmithKline Recent Developments
5.10 Amgen
5.10.1 Amgen Profile
5.10.2 Amgen Main Business
5.10.3 Amgen Autoimmune Disease Treatment Products, Services and Solutions
5.10.4 Amgen Autoimmune Disease Treatment Revenue (US$ Million) & (2018-2023)
5.10.5 Amgen Recent Developments
5.11 4SC AG
5.11.1 4SC AG Profile
5.11.2 4SC AG Main Business
5.11.3 4SC AG Autoimmune Disease Treatment Products, Services and Solutions
5.11.4 4SC AG Autoimmune Disease Treatment Revenue (US$ Million) & (2018-2023)
5.11.5 4SC AG Recent Developments
5.12 F. Hoffmann-La Roche Ltd.
5.12.1 F. Hoffmann-La Roche Ltd. Profile
5.12.2 F. Hoffmann-La Roche Ltd. Main Business
5.12.3 F. Hoffmann-La Roche Ltd. Autoimmune Disease Treatment Products, Services and Solutions
5.12.4 F. Hoffmann-La Roche Ltd. Autoimmune Disease Treatment Revenue (US$ Million) & (2018-2023)
5.12.5 F. Hoffmann-La Roche Ltd. Recent Developments
5.13 AutoImmune Inc
5.13.1 AutoImmune Inc Profile
5.13.2 AutoImmune Inc Main Business
5.13.3 AutoImmune Inc Autoimmune Disease Treatment Products, Services and Solutions
5.13.4 AutoImmune Inc Autoimmune Disease Treatment Revenue (US$ Million) & (2018-2023)
5.13.5 AutoImmune Inc Recent Developments
5.14 Johnson & Johnson
5.14.1 Johnson & Johnson Profile
5.14.2 Johnson & Johnson Main Business
5.14.3 Johnson & Johnson Autoimmune Disease Treatment Products, Services and Solutions
5.14.4 Johnson & Johnson Autoimmune Disease Treatment Revenue (US$ Million) & (2018-2023)
5.14.5 Johnson & Johnson Recent Developments
5.15 Bayer
5.15.1 Bayer Profile
5.15.2 Bayer Main Business
5.15.3 Bayer Autoimmune Disease Treatment Products, Services and Solutions
5.15.4 Bayer Autoimmune Disease Treatment Revenue (US$ Million) & (2018-2023)
5.15.5 Bayer Recent Developments
6 North America
6.1 North America Autoimmune Disease Treatment Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Autoimmune Disease Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Autoimmune Disease Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Autoimmune Disease Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Autoimmune Disease Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Autoimmune Disease Treatment Market Dynamics
11.1 Autoimmune Disease Treatment Industry Trends
11.2 Autoimmune Disease Treatment Market Drivers
11.3 Autoimmune Disease Treatment Market Challenges
11.4 Autoimmune Disease Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
